Whittier Trust Co. of Nevada Inc. reduced its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 4.7% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 10,247 shares of the medical research company’s stock after selling 508 shares during the period. Whittier Trust Co. of Nevada Inc.’s holdings in Thermo Fisher Scientific were worth $1,946,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Bank of Nova Scotia Trust Co. purchased a new position in shares of Thermo Fisher Scientific in the third quarter worth about $106,000. Ropes Wealth Advisors LLC increased its position in Thermo Fisher Scientific by 15.8% during the second quarter. Ropes Wealth Advisors LLC now owns 710 shares of the medical research company’s stock worth $124,000 after purchasing an additional 97 shares during the last quarter. Atlantic Trust LLC acquired a new stake in Thermo Fisher Scientific during the second quarter worth about $138,000. Acrospire Investment Management LLC increased its position in Thermo Fisher Scientific by 66.7% during the second quarter. Acrospire Investment Management LLC now owns 1,000 shares of the medical research company’s stock worth $174,000 after purchasing an additional 400 shares during the last quarter. Finally, SeaCrest Wealth Management LLC acquired a new stake in Thermo Fisher Scientific during the fourth quarter worth about $195,000. 86.11% of the stock is currently owned by hedge funds and other institutional investors.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of Thermo Fisher Scientific stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $191.74, for a total transaction of $9,587,000.00. Following the completion of the sale, the chief executive officer now directly owns 302,577 shares in the company, valued at $58,016,113.98. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Gregory J. Herrema sold 33,327 shares of Thermo Fisher Scientific stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $219.70, for a total transaction of $7,321,941.90. Following the sale, the senior vice president now owns 60,471 shares of the company’s stock, valued at $13,285,478.70. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 144,327 shares of company stock valued at $28,680,042. Company insiders own 0.49% of the company’s stock.

TMO has been the subject of several recent analyst reports. Deutsche Bank set a $226.00 price objective on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Thursday, October 26th. Zacks Investment Research cut shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Monday, October 30th. Leerink Swann restated a “buy” rating on shares of Thermo Fisher Scientific in a research report on Monday, October 30th. Evercore ISI initiated coverage on shares of Thermo Fisher Scientific in a research report on Wednesday, January 3rd. They set an “outperform” rating and a $220.00 price objective for the company. Finally, BTIG Research initiated coverage on shares of Thermo Fisher Scientific in a research report on Friday, January 5th. They set a “buy” rating and a $230.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $220.50.

Shares of Thermo Fisher Scientific Inc. (TMO) opened at $200.18 on Monday. Thermo Fisher Scientific Inc. has a 12-month low of $151.74 and a 12-month high of $226.44. The firm has a market cap of $80,271.26, a PE ratio of 35.75, a price-to-earnings-growth ratio of 1.47 and a beta of 1.11. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.92 and a current ratio of 1.35.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, January 31st. The medical research company reported $2.79 earnings per share for the quarter, beating analysts’ consensus estimates of $2.66 by $0.13. Thermo Fisher Scientific had a net margin of 10.64% and a return on equity of 16.01%. The business had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $5.72 billion. During the same period last year, the business earned $2.41 earnings per share. The business’s revenue for the quarter was up 22.1% on a year-over-year basis. equities research analysts anticipate that Thermo Fisher Scientific Inc. will post 10.81 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, April 16th. Shareholders of record on Thursday, March 15th will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Wednesday, March 14th. This is a boost from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.34%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is currently 10.71%.

WARNING: “Whittier Trust Co. of Nevada Inc. Decreases Stake in Thermo Fisher Scientific Inc. (TMO)” was published by Watch List News and is owned by of Watch List News. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this news story can be accessed at https://www.watchlistnews.com/whittier-trust-co-of-nevada-inc-decreases-stake-in-thermo-fisher-scientific-inc-tmo/1861503.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.